Skip to main content
Have a personal or library account? Click to login
Health System Performance for Multimorbid Cardiometabolic Disease in India: A Population-Based Cross-Sectional Study Cover

Health System Performance for Multimorbid Cardiometabolic Disease in India: A Population-Based Cross-Sectional Study

Open Access
|Jan 2022

References

  1. Bekker LG, et al. Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: The International AIDS Society-Lancet Commission. Lancet. 2018; 392: 312358. DOI: 10.1016/S0140-6736(18)31070-5
  2. Chang AY, et al. Past, present, and future of global health financing: A review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995–2050. The Lancet. 2019; 393: 22332260. DOI: 10.1016/S0140-6736(19)30841-4
  3. Barnett K, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: A cross-sectional study. Lancet (London, England). 2012; 380: 3743. DOI: 10.1016/S0140-6736(12)60240-2
  4. Kruk ME, et al. High-quality health systems in the Sustainable Development Goals era: time for a revolution. The Lancet. Global health. 2018; 6: e1196e1252. DOI: 10.1016/S2214-109X(18)30386-3
  5. Kieny MP, Evans DB, Schmets G, Kadandale S. Health-system resilience: Reflections on the Ebola crisis in western Africa. Bulletin of the World Health Organization. 2014; 92: 850. DOI: 10.2471/BLT.14.149278
  6. Essue BM, et al. In: Eds Rd et al. (eds.) Disease Control Priorities: Improving Health and Reducing Poverty (The International Bank for Reconstruction and Development/The World Bank (c) 2018 International Bank for Reconstruction and Development/The World Bank; 2017).
  7. GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390: 12601344. DOI: 10.1016/S0140-6736(17)32130-X
  8. GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390: 11511210. DOI: 10.1016/S0140-6736(17)32152-9
  9. Institute for Health Metrics and Evaluation. GBD Compare online visualization hub. Seattle, WA: IHME, University of Washington; 2015. Retrieved from http://vizhub.healthdata.org/gbd-compare. (accessed 31 August 2018).
  10. Anchala R, et al. Hypertension in India: A systematic review and meta-analysis of prevalence, awareness, and control of hypertension. Journal of hypertension. 2014; 32: 11701177. DOI: 10.1097/HJH.0000000000000146
  11. Anjana RM, et al. Prevalence of diabetes and prediabetes in 15 states of India: Results from the ICMR-INDIAB population-based cross-sectional study. The Lancet, Diabetes & endocrinology. 2017; 5: 585596, DOI: 10.1016/S2213-8587(17)30174-2
  12. Behl S, Misra A. Management of obesity in adult Asian Indians. Indian Heart J. 2017; 69: 539544, DOI: 10.1016/j.ihj.2017.04.015
  13. Yusuf S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet. 2004; 364: 937952. DOI: 10.1016/S0140-6736(04)17018-9
  14. O’Donnell MJ, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): A case-control study. Lancet. 2016; 388: 761775. DOI: 10.1016/S0140-6736(16)30506-2
  15. GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390: 13451422. DOI: 10.1016/S0140-6736(17)32366-8
  16. Geldsetzer P, et al. Geographic and sociodemographic variation of cardiovascular disease risk in India: A cross-sectional study of 797,540 adults. PLoS medicine. 2018; 15: e1002581. DOI: 10.1371/journal.pmed.1002581
  17. Gaziano TA, et al. In: Eds Rd et al. (eds.) Cardiovascular, Respiratory, and Related Disorders The International Bank for Reconstruction and Development/The World Bank; 2017.
  18. Collins R, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016; 388: 25322561. DOI: 10.1016/S0140-6736(16)31357-5
  19. Fulcher J, et al. Efficacy and safety of LDL-lowering therapy among men and women: Meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet. 2015: 385: 13971405. DOI: 10.1016/S0140-6736(14)61368-4
  20. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. Bmj. 2009; 338: b1665. DOI: 10.1136/bmj.b1665
  21. Sundstrom J, et al. Effects of blood pressure reduction in mild hypertension: A systematic review and meta-analysis. Annals of internal medicine. 2015; 162: 184191. DOI: 10.7326/M14-0773
  22. Rawshani A, et al. Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2018; 379: 633644. DOI: 10.1056/NEJMoa1800256
  23. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360: 19031913. DOI: 10.1016/S0140-6736(02)11911-8
  24. Bischops AC, et al. The prevalence of concurrently raised blood glucose and blood pressure in India: A cross-sectional study of 2035-662 adults. J Hypertens. 2019; 37: 18221831. DOI: 10.1097/HJH.0000000000002114
  25. Government of India, M. o. H. a. F. W. State/UT-wise Rural and Urban Population as Per Census during 2001 and 2011. 2011. Retrieved from https://data.gov.in/resources/state-ut-wise-rural-and-urban-population-census-during-2001-and-2011.
  26. International Institute for Population Sciences Mumbai. National Family Health Survey (NFHS-4), 201516: India Report; 2017. Retrieved from http://rchiips.org/nfhs/NFHS-4Reports/India.pdf.
  27. International Institute for Population Sciences, M. National Family Health Survey 2015–2016 Clinical Anthropometric Biochemical (CAB) Manual. 2014. Retrieved from http://rchiips.org/NFHS/NFHS4/manual/NFHS-4%20Biomarker%20Field%20Manual.pdf.
  28. Weber MA, et al. Clinical Practice Guidelines for the Management of Hypertension in the Community. The Journal of Clinical Hypertension. 2013; 16: 1426. DOI: 10.1111/jch.12237
  29. Sacks DB, et al. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Diabetes care. 2011; 34: e61e99. DOI: 10.2337/dc11-9998
  30. International Diabetes Federation. Recommendations for Managing Type 2 Diabetes in Primary Care. 2017. Retrieved from www.idf.org/managing-type2-diabetes.
  31. American Diabetes Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2018. Diabetes care. 2018; 41: S55s64. DOI: 10.2337/dc18-S006
  32. Filmer D, Pritchett LH. Estimating wealth effects without expenditure data—or tears: An application to educational enrollments in states of India. Demography. 2001; 38: 115132. DOI: 10.1353/dem.2001.0003
  33. World Health Organization Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet (London, England). 2004; 363: 157163. DOI: 10.1016/S0140-6736(03)15268-3
  34. World Heatlh Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva: World Health Organization, 2011 (WHO/NMH/NHD/MNM/11.1). http://www.who.int/vmnis/indicators/haemoglobin (accessed 30 July 2018).
  35. Zou G. A modified poisson regression approach to prospective studies with binary data. American journal of epidemiology. 2004; 159: 702706. DOI: 10.1093/aje/kwh090
  36. Abadie A, Athey S, Imbens GW, Wooldridge J. When Should You Adjust Standard Errors for Clustering? National Bureau of Economic Research Working Paper Series. 2017; 24003. DOI: 10.3386/w24003
  37. Muller LM, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clinical infectious diseases : An official publication of the Infectious Diseases Society of America. 2005; 41: 281288. DOI: 10.1086/431587
  38. Reitsma MB, et al. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990; 2015: A systematic analysis from the Global Burden of Disease Study 2015. The Lancet. 2017; 389: 18851906. DOI: 10.1016/S0140-6736(17)30819-X
  39. Grover SA, et al. Years of life lost and healthy life-years lost from diabetes and cardiovascular disease in overweight and obese people: A modelling study. The Lancet Diabetes & Endocrinology. 2015; 3: 114122. DOI: 10.1016/S2213-8587(14)70229-3
  40. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. New England Journal of Medicine. 2017; 377: 1327. DOI: 10.1056/NEJMoa1614362
  41. National Centre for Disease Control. Training module for medical officers for prevention, control and population level screening of hypertension, diabetes and common cancer (oral, breast & cervical). New Delhi: Government of India. 2017. Retrieved from https://extranet.who.int/ncdccs/Data/IND_D1_NCD%20Module%20For%20Medical%20Officers%20-%20Population%20based%20screening.pdf.
  42. National Health Resource Centre Ayushman Bharat. Comprehensive primary health care through health and wellness centers. New Delhi; 2018. Retrieved from http://www.nhm.gov.in/New_Updates_2018/NHM_Components/Health_System_Stregthening/Comprehensive_primary_health_care/letter/Operational_Guidelines_For_CPHC.pdf.
  43. Lee JT, Hamid F, Pati S, Atun R, Millett C. Impact of Noncommunicable Disease Multimorbidity on Healthcare Utilisation and Out-Of-Pocket Expenditures in Middle-Income Countries: Cross Sectional Analysis. PloS one. 2015; 10: e0127199. DOI: 10.1371/journal.pone.0127199
  44. Pati S, et al. Non communicable disease multimorbidity and associated health care utilization and expenditures in India: Cross-sectional study. BMC Health Serv Res. 2014; 14: 451. DOI: 10.1186/1472-6963-14-451
  45. Higashi, T. et al. Relationship between number of medical conditions and quality of care. N Engl J Med. 2007; 356: 24962504. DOI: 10.1056/NEJMsa066253
  46. Min LC, et al. Multimorbidity is associated with better quality of care among vulnerable elders. Med Care. 2007; 45: 480488. DOI: 10.1097/MLR.0b013e318030fff9
  47. Pati S, et al. Prevalence and outcomes of multimorbidity in South Asia: A systematic review. BMJ Open. 2015; 5. DOI: 10.1136/bmjopen-2014-007235
  48. Patel SA, et al. Chronic disease concordance within Indian households: A cross-sectional study. PLoS medicine. 2017; 14: e1002395. DOI: 10.1371/journal.pmed.1002395
  49. Singh K, et al. Multimorbidity in South Asian adults: Prevalence, risk factors and mortality. Journal of public health (Oxford, England). DOI: 10.1093/pubmed/fdy017
  50. Geldsetzer P, et al. Diabetes and Hypertension in India: A Nationally Representative Study of 1.3 Million Adults. JAMA Intern Med. 2018; 178: 363372. DOI: 10.1001/jamainternmed.2017.8094
  51. Anjana RM, et al. Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study. The Lancet. Diabetes & endocrinology. 2017. DOI: 10.1016/S2213-8587(17)30174-2
  52. United Nations Department of Economic and Social Affairs. World Population Prospects: The 2019 Revision, Key Findings and Advance Tables. New York, NY: United Nations; 2019.
  53. Whelton PK, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018; 71: 21992269. DOI: 10.1016/j.jacc.2017.11.005
  54. International Diabetes Federation. IDF Clinical Practice Recommendations for Managing Type 2 Diabetes in Primary Care. Brussels, Belgium: International Diabetes Federation; 2017.
  55. Khetan A, et al. Prevalence and pattern of cardiovascular risk factors in a population in India. Heart Asia. 2017; 9: e010931. DOI: 10.1136/heartasia-2017-010931
  56. Ghaffar A, Reddy KS, Singhi M. Burden of non-communicable diseases in South Asia. BMJ: British Medical Journal. 2004; 328: 807810. DOI: 10.1136/bmj.328.7443.807
  57. Yusuf S, et al. Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries. New England Journal of Medicine. 2014; 371: 818827. DOI: 10.1056/NEJMoa1311890
DOI: https://doi.org/10.5334/gh.1056 | Journal eISSN: 2211-8179
Language: English
Submitted on: Apr 17, 2021
Accepted on: Dec 20, 2021
Published on: Jan 31, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2022 Pascal Geldsetzer, Jan-Walter De Neve, Viswanathan Mohan, Dorairaj Prabhakaran, Ambuj Roy, Nikhil Tandon, Justine I. Davies, Sebastian Vollmer, Till Bärnighausen, Jonas Prenissl, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.